Pages that link to "Q36873046"

The following pages link to Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. (Q36873046):

Displaying 25 items.

• Epstein-Barr virus latent genes (Q28082701) (← links)
• HLA associations in classical Hodgkin lymphoma: EBV status matters. (Q34341716) (← links)
• Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects (Q35235144) (← links)
• Identification and characterization of a human cytomegalovirus gene coding for a membrane protein that is conserved among human herpesviruses (Q35495255) (← links)
• Expression of the vault RNA protects cells from undergoing apoptosis (Q35603972) (← links)
• Association of Epstein-Barr virus (EBV) with Sjögren's syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands. (Q35782417) (← links)
• Clonal Epstein-Barr virus genome in T-cell-rich lymphomas of B or probable B lineage (Q35831215) (← links)
• Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency (Q35833217) (← links)
• Absence of HLA class I expression by Reed-Sternberg cells (Q35833799) (← links)
• Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies (Q36231550) (← links)
• Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function (Q36641073) (← links)
• Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis (Q36714426) (← links)
• Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection (Q36793368) (← links)
• Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. (Q36801839) (← links)
• cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site (Q36804472) (← links)
• Identification of a glucocorticoid-responsive element in Epstein-Barr virus. (Q36805227) (← links)
• Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids (Q36828590) (← links)
• Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity (Q36881880) (← links)
• Human herpesviruses: a consideration of the latent state (Q37055693) (← links)
• Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site (Q37552683) (← links)
• Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes (Q37557660) (← links)
• Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes. (Q40049217) (← links)
• Allelic variations clustered in the antigen binding sites of HLA-Bw62 molecules (Q41581556) (← links)
• Demonstration of a unique Epstein-Barr virus-positive cellular clone in metachronous multiple localizations of Hodgkin's disease (Q42755159) (← links)
• Impaired long-term T cell immunity to Epstein-Barr virus in patients with nasopharyngeal carcinoma (Q44112947) (← links)